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Abstract
This present study aims to investigate the changes in the inflammatory markers after elective endovascular treatment of
Type B aortic dissection with aneurysm, as related to different anatomical features of the dissection flap in the paravisceral
perfusion. Consecutive patients with type B aortic dissections with elective endovascular stent graft repair were recruited
and categorized into different groups. Serial plasma levels of cytokines (Interleukin-1b, -6, -8, -10, TNF-a), chemokines (MCP-
1), and serum creatinine were monitored at pre-, peri- and post-operative stages. The length of stent graft employed in each
surgery was retrieved and correlated with the change of all studied biochemical parameters. A control group of aortic
dissected patients with conventional medication management was recruited for comparing the baseline biochemical
parameters. In total, 22 endovascular treated and 16 aortic dissected patients with surveillance were recruited. The
endovascular treated patients had comparable baseline levels as the non-surgical patients. There was no immediate or
thirty day-mortality, and none of the surgical patients developed post-operative mesenteric ischaemia or clinically
significant renal impairment. All surgical patients had detectable pro-inflammatory mediators, but none of the them
showed any statistical significant surge in the peri-operative period except IL-1b and IL-6. Similar results were obtained
when categorized into different groups. IL-1b and IL-6 showed maximal levels within hours of the endovascular procedure
(range, 3.93 to 27.3 higher than baseline; p= 0.001), but returned to baseline 1 day post-operatively. The change of IL-1b
and IL-6 at the stent graft deployment was statistically greater in longer stent graft (p.0.05). No significant changes were
observed in the serum creatinine levels. In conclusion, elective endovascular repair of type B aortic dissection associated
with insignificant changes in inflammatory mediators and creatinine. All levels fell toward basal levels post-operatively
suggesting that thoracic endovascular aortic repair is rather less aggressive with insignificant inflammatory modulation.
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Introduction
Aortic dissection is a tear in the intima (inner lining) of the aorta
followed by propagation of subintimal blood and creating a new
false channel in the media (middle layer) of the aorta [1]. It may be
complicated by rupture, aneurysmal dilatation, end organ
ischaemia, or persistent pain and discomfort [2]. Conventional
management of patients with Stanford type B aortic dissection
involves a regimen of symptomatic pain relief with diligent blood
pressure control. Meta-analysis has shown that endovascular
stentgrafts repair is preferable to convention open surgery with
lower rate of peri-operative mortality and complication [3]. The
procedure involves covering the primary intimal entry tear with a
stentgraft, followed ideally by depressurization and thrombosis of
the false lumen, at the expense of the true lumen [4]. This
treatment alleviates pain, limits further dissection, and prevents
aneurysm formation and other complications, although the verdict
is still out as to long-term survival benefit [5,6].
Though the immunological sequelae of less invasive endovas-
cular treatment of aortic dissection would understably be more
favourable with potentially lower risk of systemic inflammatory
response syndrome (SIRS) and organ failure than open surgery,
the placement of the stent grafts may cause haemodynamic
changes within the aorta [7], and causes different blood flow in the
mesenteric (celiac axis, superior mesenteric artery, renal arteries)
arteries that may cause end-organ perfusion during the peri- and
post-operative process, with tissue damage and ischaemia reper-
fusion insult [8,9]. Therefore, there were still obvious post-
implantation inflammatory response after endovascular aneurysm
aortic repair in many clinical studies [10–12].
To date, the magnitude inflammatory markers released and
end-organ response caused by disturbances of visceral blood flow
in endografting of thoracic aortic dissections is unknown and no
published reports on any similar observations for thoracic aortic
stenting. The present study was undertaken to determine the
degree and pattern of circulating inflammatory markers released at
pre-, peri- and post-operative stages of elective endovascular stent
grafting for chronic type B aortic dissections with aneurysmal
changes. Inflammatory changes with respect to different anatom-
ical features of the dissection flap and comparison of the basal
levels of inflammatory mediators and creatinine between endo-
vascular treated patients and conventional medically treated
patients were also assessed.
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Materials and Methods
Patient groups
Patients with chronic type B aortic dissection with aneurysmal
changes with either endovascular stent graft repair using Zenith
Endovascular system (Cook Medical, Bloomington, Ind, USA) or
with high blood pressure control only (as control group) were
recruited for the study. Written consent was obtained from all
patients. The study was approved by the Hong Kong West
Cluster- The University of Hong Kong Research Ethics Commit-
tee/Institutional Review. All endovascular procedures were
performed by the same surgical team according to a standard
vascular protocol and under general anaesthesia. The operative
data including the blood loss and amount of contrast media
administered were recorded.
Categorization of patients according to anatomical
differences of dissected flap with respect to visceral
branches
The patency of visceral vessels and their origin from the true
and false lumens were assessed by computed tomography pre-
operatively. All patients were categorized into the following three
groups (Figure 1): all visceral arteries including the celiac artery
(CA), the superior mesenteric artery (SMA) and the renal artery
(RA) were supplied by the true lumen (group 1); either the CA,
SMA or 1 RA were supplied by the false lumen (group 2); and
both CA, SMA, and one or both RA were supported by the false
lumen (group 3) (Figure 1 A, B and C)
Collection of blood samples
Peripheral venous blood samples were obtained at (1) pre-
operatively (as baseline) and (2) at the time of endograft
deployment (designated at 0, J, K, 1, 3, 6, 24, 48 hours) post-
operatively after endovascular treatment and (3) at the first follow-
up clinic (9 days post-operatively). The blood was immediately
separated into two samples for serum and plasma (Vacuette,
Greiner Bio-One, Kremsmu¨nster, Austria). Samples were centri-
fuged within 30 minutes at 3000 g for 15 minutes at 4uC (Jouan
BR4, Saint-Herblain, France). The serum and plasma fractions
were then pipetted into 1 ml aliquots in polypropylene microtubes
(Axygen, California, USA) and were immediately frozen and
stored at 280uC until further analysis.
Detection of plasma inflammatory markers
Freshly thawed plasma samples were assayed for the most
common pro-inflammatory mediators involved in the SIRS
[13,14], including interleukins (IL-1b, IL-6, IL-8, and IL-10),
monocyte chemotactic protein 1 (MCP-1), and tumour necrosis
factor (TNF)-a. Enzyme-linked immunosorbent assays (ELISA)
using commercially available matched monoclonal and biotiny-
lated antibody pairs (R & D Systems, Minneapolis, Minnesota,
USA) were carried out. All measurements were performed in
duplicate and concentrations of these mediators were determined
using constructed standard curves.
Detection of serum creatinine
Serial measurement of serum creatinine levels for renal function
assessment during the study period were performed in the
Department of Clinical Biochemistry at the Queen Mary Hospital.
Renal impairment was described as clinically significant if the
change of serum creatinine levels exceeded the baseline value by
25% [15], although more definitive evidence of renal ischaemia
using creatinine clearance was not used in this study.
Statistical analysis
All concentrations of inflammatory markers were expressed as
mean 6 standard deviation (S.D). One-way analysis of variance
(ANOVA) was used to analyze the data recorded over the
monitoring period and to compare between the different test
groups. (SPSS version18). Where data were non-parametric, the
Wilcoxon and Mann-Whitney U test were used for comparison
with and between the study groups respectively. The Pearson
correlation test was used to determine any correlation between
serum creatinine levels upon the stent graft deployment and the
amount of contrast medium administered. Differences were
considered statistically significant for p,0.05.
Results
A total of twenty-three patients with chronic type B aortic
dissecting aneurysm who underwent endovascular repair were
recruited in the study. One patient with concomitant Marfan
syndrome was excluded, as Marfan patients with thoracic aortic
aneurysms were found to have increased levels of inflammatory
infiltrates [16]. The remaining 22 patients were 15 males, 7
females. (age range 48–78 years).
For the basal inflammatory mediators’ comparison, 16 age-
matched aortic dissected patients (10 acute cases) were recruited
for the study. The demographic data, incidence of pre-operative
Figure 1. Three-dimensional computed tomography images showing the anatomical features of the dissection flap in relation to
the visceral arteries of the three groups of patients. (A) Group 1, all visceral arteries including celiac artery (CA), superior mesenteric artery
(SMA) and renal artery (RA) were supported by true lumen; or (B) group 2, either CA or RA were supported by false lumen; and (C) group 3, both CA
and RA were supported by false lumen.
doi:10.1371/journal.pone.0037389.g001
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risk factors and operative data of the all patient groups were shown
in Table 1. No difference between the acute and chronic aortic
dissected patients in the control group can be found and so all
medically treated patients (both acute and chronic) were grouped
into one control group for the subsequent baseline comparison
(Table 2). There were no statistical difference of the detected
inflammatory mediators and serum creatinine between the basal
levels of endovascular treated patients and control patients
(Table 2).
For the study of anatomical differences of dissection flaps,
patients were further categorized into three different groups
accordingly (group 1, n= 7; group 2, n = 8; group 3, n= 7). All
patients recovered well clinically. There was no immediate or
thirty day-mortality, and none of the patients developed post-
operative mesenteric ischaemia or clinically significant renal
impairment.
All patient groups were comparable in terms of demographic
data (with or without endovascular treatment), exposure to
contrast dye and blood loss (with different anatomical differences
respect to the dissection) (Table 1). For the endovascular treated
patients groups, all patients had detectable pro-inflammatory
cytokines and chemokine, but none of the individual single
inflammatory mediator had statistical significant surge during the
per-operative or post-operative period. The results were the same
when patients were categorized into the different groups. Only
plasma IL-1b and IL-6 levels in all patients peaked in a
monophasic pattern within hours (range, 3.93 to 27.3 higher than
baseline; p=0.001) and decreased significantly within 6 hours, and
approached baseline level by 24 hours (Figure 2). IL-8 had a rise
trend within an hour of graft deployment and then decreased
reaching pre-operative levels, but did not reach statistical
significant. Other inflammatory markers did not change signifi-
cantly at any time point (Figure 2 and 3). Twelve of total stent
grafts employed in the study were 127 mm long and the remaining
lengths were 152 mm. The longer length of the stent graft per OT
record was found to have higher change of the surge of IL-1b and
IL-6 (p.0.05)
There was no statistically significant difference in the renal
function as dictated by serum creatinine among the three groups
(Figure 4) and in the two different length of stent graft. Only a
transient creatinine change was noted and the transient renal
impairment may be due to peri-operative contrast load or blood
loss, with none of the patients suffered from any clinically
significant renal impairment post-operatively. Serum creatinine
levels tended to increase around 3 hours in all groups, but this
increase was not statistically significant (ANOVA, p.0.05).
Patients in Group 2 had the highest pre-operative serum creatinine
baseline levels among the three groups. For all three groups of
patients, the amount of contrast medium administered varied from
80 to 220 ml. No statistical association was found between serum
creatinine levels and the amount of contrast medium administered
(Pearson coefficient r=0.68, p.0.05).
Table 1. Characteristics of type B aortic dissection patients.
Thoracic endovascular
aortic repaired group
Surveillance
control group
(n = 22)
(15M: 7F, 48–78 yrs)
Group 1
(n = 7)
Group 2
(n = 8)
Group 3
(n = 7)
(n = 16)
(11M: 5F, 52–75 yrs)
(n = 16)
Demographic data
Age (Mean age 6 S.D.) 60.5611 yrs 6668.8 yrs 6069.4 yrs 6565.5 yrs
Gender (Male %) 85.7% (6/7) 62.5% (5/8) 57.1% (4/7) 68.8% (11/16)
History of
Smoking (%) 57.1%(4/7) 62.5% (5/8) 42.8% (3/7) 62.5%(10/16)
Hypertension (%) 85.7% (6/7) 50% (4/8) 42.8% (3/7) 50% (8/16)
Diabetes (%) 14.2% (1/7) 12.5% (1/8) 14.2% (1/7) 12.5% (2/16)
Cardiac Disease (%) 14.2% (1/7) 12.5% (1/8) 0% (0/7) 0% (0/16)
Renal disease (%) 0% (0/7) 0% (0/8) 0% (0/7) 0% 0/16)
Operative data
Amount of contrast medium 110–200 ml 80–220 ml 160–220 ml -
Blood loss 100–150 ml 100–160 ml 100–150 ml -
doi:10.1371/journal.pone.0037389.t001
Table 2. Inflammatory mediators and creatinine levels in
both groups of patients.
Thoracic endovascular
aortic repaired group
Surveillance
control group
n= 22 n= 16
Biochemical parameters
Plasma IL-6 (pg/ml) 160.5 0.560.8
IL-8 (ng/ml) 861 663
IL-1b (pg/ml) 7.561 863
MCP-1 9 pg/ml) 267660 290680
TNF-a (pg/ml) 2863 3065
IL-10 (pg/ml) 460.6 4.662
Serum creatinine (um/L) 110616 106622
doi:10.1371/journal.pone.0037389.t002
Inflammatory Response in Aortic Dissection
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37389
Discussion
This study is the first published literature to quantify most
common pro-inflammatory mediators in a cohort of patients who
underwent endovascular treatment for aneurysmal dilatation for
chronic type B aortic dissection though no difference were
observed regardless of whether the visceral arteries originated
from true or false lumen. A recent study demonstrated higher IL-6
in acute aortic dissection than that in hypertension and healthy
controls, in which no significant different between with or without
endovascular treated patients, and no difference between acute
aortic dissection and chronic aortic dissection were found and
same did our result [17]. Thus, both acute and chronic patients
were grouped into the same control group for baseline comparison
in the present study.
Our serological study probably covered an appropriate time
course and indicated no significant change of parameters with no
complications, which supports the notion that endovascular repair
is rather less aggressive with insignificant inflammatory modula-
tion and may complementary to some promising early results of
recent clinical studies [5,6,18–21]. Until now, there were only two
published studies concerning the inflammatory response in the
Figure 2. Plasma IL-6, IL-8 and IL-1 b detected concentrations along the time course of endovascular stent grafting for type B aortic
dissection patients. Group 1 (solid circles), visceral arteries including celiac artery (CA), superior mesenteric artery and renal artery (RA) were all
supported by true lumen (n = 7); group 2 (solid squares), either CA or RA were supported by false lumen, others from true lumen (n = 8); group 3
(solid triangles), both CA and RA were supported by false lumen (n = 7). Blood samples were obtained at different time intervals as stated in ‘‘Materials
and Methods’’. Values expressed as mean6S.E.M. The zero hour point on the x-axis represents the deployment of stent graft. All levels except IL-8
significantly peaked within a hour and then decreased reaching pre-operative levels. * p = 0.001 for differences in values between the baseline and
peak values. No significant differences can be found among the three groups of patients. Detected levels after 24 hours were not shown because all
levels of cytokines returned to baseline at 2 and 9 days post-operatively.
doi:10.1371/journal.pone.0037389.g002
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thoracic aortic pathology after endoluminal stenting but without
data on the exact changes of the most important pro-inflammatory
mediators at the peri-operative stage [22,23].
There were no intra-group differences in all the tested
parameters indicating neither the landing zone of the diseased
aorta with false lumen compression or the redistribution of blood
caused any potentially adverse outcomes. It implies no additional
specific risk with respect to anatomy of the dissected flaps. The
results may supplement with the study of Melissano et al, which
found that such treatment is safe and does not affect the patency of
the branches covered by the bare stent [24].
The incidences of post-implantation syndrome vary widely
between 14% and 60% for abdominal aortic aneurysm and
intervention was suggested to cause white cell activation with the
release of various cytokines, such as IL-1, IL-6, and TNF-a [25].
Therefore, we specifically analysed IL-1b, IL-6, IL-8, IL-10, TNF-
a and MCP-1 as these pro-inflammatory mediators constitute a
significant source of morbidity after endovascular AAA repair in
most studies [12–14,16,25,26].
Figure 3. Plasma IL-10, MCP-1 and TNF alpha detected concentrations along the time course of endovascular stent grafting for type
B aortic dissection patients. Group 1 (solid circles), visceral arteries including celiac artery (CA), superior mesenteric artery and renal artery (RA)
were all supported by true lumen (n = 7); group 2(solid squares), either CA or RA were supported by false lumen, others from true lumen (n = 8);
group 3 (solid triangles), both CA and RA were supported by false lumen (n = 7). Blood samples were obtained at different time intervals as stated in
‘‘Materials and Methods’’. Values expressed as mean6SEM. The zero hour point on the x-axis represents the deployment of stent graft. All detected
cytokines did not appear to vary in each group of patients.
doi:10.1371/journal.pone.0037389.g003
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The longer length of the stent graft per OT record was found to
have significant change of IL-1b and IL-6 than shorter stent graft.
The stent graft deployment definitely covered portions of spinal
arteries which may cause decreased perfusion of spinal cord, and
ultimately increase the release of interleukins, though no
paraplegia clinically. It may be explained by the increased IL-6
level was found in the injured spinal cord of the experimentally
ooccluded rat aorta [27]. Pro-inflammatory cytokine IL-b has also
been implicated in extensive inflammation and progressive
neurodegeneration after ischemia. [28] Since the longer the
stentgraft, the more spinal arteries covered, and therefore the
endovascular surgery may be relating to some extent of spinal
ischaemia that implied by the interleukins’ surge.
Our study may provide some insights into the biological
responses upon endovascular repair. In all patients, both IL-1b
and IL-6 cytokines quickly increased and returning to baseline
within 1 day post-operatively. Indeed, both cytokines, particularly
IL-6, are important pro-inflammatory mediators that can be easily
detected in blood and will rise in many kinds of surgery [29].
Physiologically, IL-6 can cause the activation of leukocytes and
promotion of TNF-a release and accounts for fever and
leukocytosis present in systemic inflammatory response syndrome
(SIRS) [26,30]. Massive cytokines release is also disadvantageous
in terms of the induction of polymorphonulcear leukocyte elastase
and active oxygen radicals, which cause injury to parenchymal
and vascular endothelial cells, ultimately leading to organ
dysfunction [31]. Low levels of IL-6 have been noted as a
favourable inflammatory response to endoluminal repair of AAA
[32]. Our result is agreed with another recent study which
observed no elevated cytokines at 24 hours pre-and 24 hours post-
operatively for aneurysmal patients [10]. Thus, our finding of
acute elevated IL-1b and IL-6 levels may perhaps occur in
response to the deployment of the stent graft as a ‘foreign body’ or
as stent-graft-induced aortic healing processes such as false lumen
thrombosis.
In the present study, all the patients had Cook Zenith stent
(Bloomington, Ind, USA) graft that was designed with a low-
permeability Dacron fabric which is made of polyester material
attached to a frame of stainless-steel stents. Indeed, no significant
difference was apparent in the biological response between
patients receiving a polyester or an expanded polytetrafluoroeth-
ylene stent graft, except for serum concentrations of IL-8 [26].
This may explain why the use of the polyestergraft resulted in
insignificant changes in most cytokines coincidence with only a
small rise trend of IL-8. It should also be noted that the stent used
to support endograft vary in construction, and that their
configuration may influence their ability to affect renal function
[33]. Therefore, the homogeneity of Zenith endograft implants
used in this study may account for the insignificant inflammatory
response and renal function variation.
A meta-analysis of 39 international studies of 609 patients who
underwent endovascular treatment for type B dissection showed a
technical success rate in excess of 95% [34]. They also found more
stent grafts deployed per patient corresponded with higher levels of
inflammatory markers [19]. Therefore, despite a technically
successful procedure, aortic dissected patients with complex
procedure continue to be at risk of further complications, like
SIRS if more stent grafts were deployed in the endovascular
repair.
No significant serum creatinine change was noted in all patients.
A previous study found that a 10% decrease in creatinine
clearance in the first year after endovascular aneurysm repair
with no reason [35]. Thus, further experimental investigation and
long term follow-up to monitor creatinine levels with renal
imaging and regular blood pressure measurements is needed to
dictate any cause and detect any late renal dysfunction in
endovascular repaired patients.
No significant association between administrated contrast
medium and serum creatinine change was found, even though
peri-operative creatinine changes are likely influenced by the
duration of the procedure, anaesthetic agents, and nephrotoxic
contrast media [36]. This promising outcome may be explained by
the efficient peri-operative protocols for hydration and the
minimal use of contrast media during the endovascular procedure.
Figure 4. Serum creatinine detected concentrations (indication of renal function) along the time course of endovascular stent
grafting for type B aortic dissection patients. Group 1 (solid circles), visceral arteries including celiac artery (CA), superior mesenteric artery and
renal artery (RA) were all supported by true lumen (n = 7); group 2 (solid squares), either CA or RA were supported by false lumen, others from true
lumen (n = 8); group 3 (solid triangles), both CA and RA were supported by false lumen (n = 7). Serum creatinine levels were increased from baseline
4 hours after endograft deployment in only group 2 but this was not statiscally significant (p = 0.09).
doi:10.1371/journal.pone.0037389.g004
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The highest serum creatinine pre-operative value was found in
patient with either CA, SMA or RA supported by the false lumen.
This finding could be of interest for further research.
There are a few shortcomings and criticisms. Sample size is
relatively small in each group. The peri-operative complication
rates were very low, and none of the patients suffered end-organ
ischaemia. We only focused on the acute phase inflammatory and
renal responses, so the association of inflammatory markers with
long-term outcomes was overlooked. In addition, no screening for
other co-existing diseases such as subclinical infection, poorly
controlled diabetes, cancer, all of which may cause rise in these
inflammatory markers. The present renal impairment is checked
by the creatinine change, which may not be a good indicator of
renal insult [15]. Luckily, none of the patient suffered any severe
bowel/renal ischaemia.
Nevertheless, our study design explored the changes in the
inflammatory markers in thoracic endovascular aortic repair
patients with control patients. Thus, an appropriate comparison of
the magnitude of the inflammatory responses can be made.
Although our preliminary data does not indicate any significant
acute inflammatory responses, the possibility for an inflammatory
response or renal impairment resulting from thoracic aortic
endografting repair in the long-term should be further investigat-
ed.
In conclusion, patients who recovered well clinically after
endovascular stent graft repair for chronic type B aortic dissecting
aneurysm did not have a significant inflammatory response nor
impairs renal function, despite considerable pressure and flow
changes occurring in the aorta. Similar results were observed in
stenting performed in a variety of anatomical dissected flaps
respect to visceral braches. The results may help us to gain some
insight into the inflammatory sequelea of the underlying patho-
physiology during the implantation of endovascular stent graft.
The findings supported the notion that endovascular aortic repair
is rather less aggressive with insignificant inflammatory changes
and may indicate a potential use of this rather safe and effective
treatment for type B aortic dissection patients. Those inflamma-
tory mediators may also be further explored as useful biological
markers to predict a good outcome.
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